FDA Drug recall D-0716-2018
Diltiazem HCl Extended-Release Capsules, USP 240 mg, 100-count bottles, Rx Only, Mfg
- FDA Drug
- Class III
- terminated
- Published 2018-05-02
On 2018-05-02 the FDA classified a Class III recall of Diltiazem HCl Extended-Release Capsules, USP 240 mg, 100-count bottles, Rx Only, Mfg by Mckesson Packaging Services, citing failed Dissolution Specifications. High dissolution results were obtained during stability testing.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0716-2018 |
| Classification | Class III |
| Status | terminated |
| Initiated | 2018-04-23 |
| Published | 2018-05-02 |
| Last updated | 2026-09-13 11:52 UTC |
| Company | Mckesson Packaging Services |
| Distribution | US |
Product
Diltiazem HCl Extended-Release Capsules, USP 240 mg, 100-count bottles, Rx Only, Mfg. By: Par Pharmaceutical One Ram Ridge Rd Chestnut Ridge, NY 10977. NDC: 63739-016-10
Reason
Failed Dissolution Specifications. High dissolution results were obtained during stability testing.
Identifiers
| code_info | Lot #: 0115087, Exp. 12/2018 |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0716-2018%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.